Results 221 to 230 of about 26,462 (230)

Absorption, distribution, metabolism and excretion of the P2Y12 receptor antagonist selatogrel after subcutaneous administration in healthy subjects

Xenobiotica, 2020
Mike Ufer, Jasper Dingemanse
exaly  

Expression and Localization of Purinergic P2Y12 Receptor in Human Nasal Mucosa

Allergology International, 2013
Hideaki Shirasaki
exaly  

Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry

European Heart Journal, 2019
Björn Redfors, Christian F Dworeck, Oskar Angerås   +2 more
exaly  

Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury

Neuroscience, 2016
Przemyslaw Swiatkowski, Ukpong Eyo, Srikant Rangaraju   +2 more
exaly  

Ticagrelor: The First Reversibly Binding Oral P2Y 12 Receptor Antagonist

Cardiovascular Therapeutics, 2009
exaly  

Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function

Basic Research in Cardiology, 2018
Michael V Cohen, Diego F Alvarez, Jonathon Audia   +2 more
exaly  

The platelet P2Y12 receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [3H]PSB-0413

Purinergic Signalling, 2012
Anna Lecchi, Christa E Müller, Marco Cattaneo   +2 more
exaly  

Clinical Pharmacology of P2Y12 Receptor Inhibitors

Claudio Laudani, Davide Capodanno, Dominick J. Angiolillo   +2 more
openaire   +1 more source

Platelet P2Y12 Receptor Inhibition and Perioperative Patient Management

Anesthesiology
Michael Mazzeffi, Kenichi A. Tanaka, Paul A. Gurbel, Udaya S. Tantry, Jerrold H. Levy   +4 more
openaire   +2 more sources

Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists

Journal of Thrombosis and Thrombolysis, 2009
openaire   +2 more sources